Dr. Fahad Shahjahan, MD

Dr. Shahjahan practices at Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health.

Dr. Shahjahan's NPI, 1558781450, was assigned on April 18, 2014. Dr. Shahjahan holds Michigan license 4301105592.

Dr. Shahjahan's primary practice is Corewell Health William Beaumont University Hospital, at 3601 W Thirteen Mile Rd, Royal Oak, MI 48073 in Oakland County. The practice phone is (248) 898-5400.

Dr. Shahjahan's primary practice is Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health. Dr. Shahjahan is also affiliated with University of Michigan Health-Sparrow Lansing. The medical group on file is Harmony Medical Group. Dmand AI also links Dr. Shahjahan to 2 more hospitals, 5 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shahjahan practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Shahjahan's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Shahjahan is licensed in Michigan.

CMS data shows 921 Medicare services from Dr. Shahjahan across 6 procedure codes in 2024, for 345 Medicare patients. Medicare paid $78,173 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 345 Medicare patients who saw Dr. Shahjahan in 2024. The largest group is 75 to 84, with 119 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 36% are also on Medicaid. Their average risk score is 2.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shahjahan's median patient age at 69, with 48% women.

In 2024, Dr. Shahjahan wrote 478 Medicare Part D claims for 224 patients. 87% of them were for generic drugs. CMS names the drug for 231 of them, across 15 drugs with 11 or more claims each, at $7,743 in total drug cost. In 2023, CMS named 176 claims across 9 drugs.

Dr. Shahjahan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Dr. Shahjahan from 2 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Medtronic Vascular, Inc. paid the most, $77.